Ardelyx reported $28.28M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8983M 107M
Amgen AMGN:US $ 3.74B 804M
Ardelyx ARDX:US $ 28.28M 8.03M
Astrazeneca AZN:US 10.51B 1.79B
Biocept BIOC:US $ 22.65M 5.9M
Chimerix CMRX:US 24.79M 14.79M
Corcept Therapeutics CORT:US $ 66.92M 4.76M
Curis CRIS:US $ 17.19M 1.49M
Life Technologies LIFE:US $ 12.38M 3.74M
Opko Health OPK:US $ 401.64M 62.77M
Tg Therapeutics TGTX:US $ 68.89M 26.38M
United Therapeutics UTHR:US $ 175.6M 69.8M
Xoma XOMA:US $ 5.17M 408K